Elpiscience (suzhou) Biopharma, Ltd.

This study tests a new drug called ES014 in 50 adults with desmoid tumors, a rare type of growth that can cause pain and other problems. The goal is to see if ES014 can shrink or control the tumors and improve quality of life. Participants must have tumors that are growing or cau…

This study tests a new drug (ES102) combined with an immunotherapy (toripalimab) in 40 adults with advanced non-small cell lung cancer that has not responded to prior treatments. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must …